(Q40048436)
Statements
1 reference
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist (English)
1 reference
1 reference
Bridget Charbonneau
1 reference
Timothy L Ratliff
1 reference
Andrew D Weinberg
1 reference
1 December 2007
1 reference
1 reference
7244-7253
1 reference
Identifiers
1 reference